Coxsackievirus infection
Enfermedad mano-pie-boca
Revisado por pares por Dr Philippa Vincent, MRCGPÚltima actualización por Dr Rosalyn Adleman, MRCGPÚltima actualización 22 May 2025
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
- Agregar a fuentes preferidas en Google
Profesionales Médicos
Los artículos de Referencia Profesional están diseñados para ser utilizados por profesionales de la salud. Están escritos por médicos del Reino Unido y se basan en evidencia de investigación, así como en guías del Reino Unido y Europa. Puede encontrar el Enfermedad mano-pie-boca artículo más útil, o uno de nuestros otros artículos de salud.
En este artículo:
Continúa leyendo abajo
What is a Coxsackievirus?
The Coxsackieviruses are common pathogens causing a number of diseases, of which the most common is hand, foot and mouth disease (HFMD).
Virology
Volver al contenidoThe Coxsackieviruses are RNA viruses of the Picornaviridae family, Enterovirus genus which includes echoviruses and polioviruses. Infections are often asymptomatic. They are divided into groups A and B:
Coxsackievirus A:
Usually affects skin and mucous membranes.
Causes herpangina and HFMD.
There are a number of different viruses within the group. The most common causes of HFMD are Coxsackievirus A16 (CA16) along with the closely related enterovirus 71 (EV71).
Coxsackievirus B:
Usually affects the heart, lungs, pancreas and liver.
Causes Bornholm disease, hepatitis, myocarditis and pericarditis.
Coxsackieviruses of both types are a leading cause of aseptic meningitis. They may also cause nonspecific febrile and upper respiratory tract illnesses.
Spread is usually from the faeco-oral route or oral-oral route, with an incubation period of 2-6 days.
The virus is named after the town of Coxsackie in New York State.
Continúa leyendo abajo
Epidemiología1
Volver al contenidoInfection with this group of enteroviruses is very common. In temperate climates, it is most frequent in summer and autumn and, in the tropics, all year round.
Enterovirus disease, particularly HFMD tends to affect those aged under 10 but children of any age and adults can also be affected. It occurs worldwide, both on a sporadic basis and in epidemics. There have been a number of serious outbreaks of HFMD in the Western Pacific region. China has led the quest for vaccines, following a major outbreak with fatalities.
In the UK outbreaks occur regularly in nurseries, schools and childcare centres. Most adults have developed immunity.
Coxsackievirus symptoms
Volver al contenidoEnfermedad mano-pie-boca1
Most often caused by CA16 and the closely related EV71. Subtypes A 6 and 10 can also cause it but it can result from infection with other group A or B viruses.2 3
Usually a mild illness with a prodromal phase, followed by tender oral ulcerative lesions and then usually maculopapular lesions on the hands and feet; and sometimes the buttocks.
Rarely there are neurological or other complications which can be very severe.
See the separate article Enfermedad mano-pie-boca for more information.
Herpangina4
Incubation period of about four days.
Affects mainly children up to the age of 10.
Mild pyrexia, headache, sore throat, dysphagia, loss of appetite and sometimes vomiting and abdominal pain.
Red spots appear on the uvula, soft palate and tonsils which develop into tiny grey-white papulovesicles, about 1 mm or 2 mm in diameter .
There is an erythematous halo, which progresses to a shallow ulcer.
It is caused mainly by CA16 but can involve other Coxsackievirus A serotypes and occasionally Coxsackievirus B (serotypes 1-5 ).
It resolves uneventfully in 5-10 days.
Enfermedad de Bornholm
Usually caused by Coxsackievirus B.
Pain on inspiration is similar to pleuritic pain and pulmonary embolism may be suspected. The muscles are locally tender.
Fever, headache or nonspecific abdominal pain - either as prodromal symptoms or with the onset of chest pain. May be myalgia elsewhere.
Duration is normally a few days, but may be ≤3 weeks; it can recur/relapse.
See the separate article Enfermedad de Bornholm.
Miocarditis
Coxsackievirus B is one of the more common causes of myocarditis, with potential to progress to dilated cardiomyopathy.5
Viral myocarditis may be asymptomatic, or may present with symptoms of heart failure and left ventricular dysfunction.
See the separate article Miocarditis for more information.
Pericarditis
Coxsackievirus B is one of the more common causes of pericarditis.
The cardinal presenting symptom is dolor en el pecho. Typically, sharp, stabbing, central chest pain.
Meningitis aséptica6
Coxsackieviruses are one of the most common causes of aseptic (viral) meningitis.
In particular A and B viruses are involved.
There is a peak in summer months.
See the separate article Meningitis for more information.
Other clinical conditions
Coxsackie A viruses can cause a haemorrhagic conjunctivitis.
Coxsackievirus B5 causes pustular stomatitis with eritema multiforme.
Coxsackievirus A4 causes a widespread vesicular eruption.
There has been some investigation into Coxsackievirus B4 as a possible part of the aetiology of type 1 diabetes mellitus. There are also possible associations of Coxsackieviruses with postviral fatigue syndromes, Reye's syndrome and pancreatitis.
Coxsackievirus B1 has been reported as causing severe infection and death in neonates in America in 2007-2008.7
Continúa leyendo abajo
Investigaciones1
Volver al contenidoUsually diagnosis is clinical but some laboratory tests are available.
El virus puede aislarse de muestras de garganta, vesículas o rectales (colocadas en medio de transporte viral) o de cultivos fecales. La eliminación viral en las heces puede ser intermitente, por lo que puede ser necesario más de un espécimen.
IgM with enzyme-linked immunosorbent assay (ELISA) can aid diagnosis. Blood samples are required in the acute phase because IgM disappears rapidly.
La reacción en cadena de la polimerasa (PCR) ha hecho posible la subtipificación de enterovirus y es cada vez más la prueba de elección en centros especializados, aunque rara vez se utiliza en la práctica clínica rutinaria.
Coxsackievirus treatment1
Volver al contenidoThere is no known treatment for Coxsackievirus infections, so management is supportive
For HFMD/herpangina:
Reassurance, and encourage adequate fluid intake.
Antipyretic analgesics such as paracetamol and ibuprofen are the main treatment.
Topical oral analgesic options are available although there is no evidence of efficacy and some cannot be used by children. Examples are lidocaine oral gel, benzydamine oral rinse or spray, choline salicylate oral gel, warm salty mouthwashes.
For other conditions:
Antiviral agents are not indicated. There is ongoing research into potential anti-viral agents and several show promise but are not yet at the clinical trial stage. 8
Consejos para mujeres embarazadas1
There are no known adverse consequences for the fetus if a pregnant woman is in contact with HFMD.
Seek specialist advice if a woman develops HFMD within three weeks of expected delivery, as there may be a risk of passing the infection to the newborn. In rare cases this can lead to severe infection in the neonate, although usually illness is mild.
Coxsackievirus B may cause an increase in early spontaneous abortions, stillbirths and (rarely) fetal myocarditis.9 10
Coxsackievirus prognosis1
Volver al contenidoThese diseases tend to be self-limiting, although there are occasional case reports of adult fatalities.
The prognosis of HFMD is excellent, with the vast majority resolving spontaneously in 5-10 days. Those cases caused by Coxsackieviruses have less risk of developing neurological complications than those caused by EV17, although they can do very occasionally.
Aseptic meningitis usually resolves without sequelae but encephalitis is more likely to have adverse outcomes.
Although prognosis for those with Coxsackie B myocarditis or pericarditis is generally good, there are risks of complications such as dilated cardiomyopathy, dysrhythmias, cardiac failure and sudden cardiac death.
Coxsackievirus prevention
Volver al contenidoGood hygiene measures reduce spread of Coxsackieviruses within the family. Advise careful handwashing and drying after using the toilet. Advise against sharing cups, eating utensils, towels and clothing. Advise covering of the mouth and nose when coughing and sneezing, and hygienic disposal of tissues used.
Actualizaciones exclusivas para profesionales de la salud
Mantente informado con las últimas actualizaciones clínicas, perspectivas profesionales y orientación basada en evidencia. El boletín de Patient Pro selecciona contenido esencial para profesionales de la salud, entregado directamente en tu bandeja de entrada.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.
Lecturas adicionales y referencias
- Zhang M, Wang H, Tang J, et al; Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021 Mar 15;21(1):127. doi: 10.1186/s12887-021-02599-y.
- Enfermedad mano-pie-boca; NICE CKS, septiembre 2024 (acceso solo en el Reino Unido)
- Downing C, Ramirez-Fort MK, Doan HQ, et al; Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. J Clin Virol. 2014 Aug;60(4):381-6. doi: 10.1016/j.jcv.2014.04.023. Epub 2014 May 9.
- Kimmis BD, Downing C, Tyring S; Enfermedad mano-pie-boca causada por el coxsackievirus A6 en aumento. Cutis. 2018 Nov;102(5):353-356.
- Herpangina; DermNet NZ
- Brunetti L, DeSantis ER; Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm. 2008 Jan 15;65(2):132-7. doi: 10.2146/ajhp060586.
- Meningitis - meningitis bacteriana y enfermedad meningocócica; NICE CKS, diciembre 2024 (acceso solo en el Reino Unido)
- Wikswo ME, Khetsuriani N, Fowlkes AL, et al; Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008. Clin Infect Dis. 2009 Sep 1;49(5):e44-51.
- Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics; Vaccines, 2023
- Ornoy A, Tenenbaum A; Resultado del embarazo tras infecciones por los virus coxsackie, echo, sarampión, paperas, hepatitis, polio y encefalitis. Reprod Toxicol. Mayo 2006;21(4):446-57. Publicado en línea el 9 de febrero de 2006.
- Hwang JH, Kim JW, Hwang JY, et al; Coxsackievirus B infection is highly related with missed abortion in Korea. Yonsei Med J. 2014 Nov;55(6):1562-7. doi: 10.3349/ymj.2014.55.6.1562.
- Mao Q, Wang Y, Yao X, et al; Coxsackievirus A16: epidemiología, diagnóstico y vacuna. Hum Vaccin Immunother. 2014;10(2):360-7. doi: 10.4161/hv.27087. Epub 2013 Nov 14.
- Li L, Yin H, An Z, et al; Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine. 2015 Feb 25;33(9):1107-12. doi: 10.1016/j.vaccine.2014.10.081. Epub 2014 Nov 8.
- Liang Z, Wang J; Vacuna EV71, un regalo invaluable para los niños. Clin Transl Immunology. 31 de octubre de 2014;3(10):e28. doi: 10.1038/cti.2014.24. eCollection octubre de 2014.
Continúa leyendo abajo
Sobre el autorVer biografía completa

Dr Rosalyn Adleman, MRCGP
MRCGP
La Dra. Rosalyn Adleman es una médica de cabecera del NHS que trabaja en el norte de Londres.
Acerca del revisorVer biografía completa

Dra. Philippa Vincent, MRCGP
Médico General, Autor Médico
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dra Philippa Vincent es un médico de cabecera del NHS que trabaja en el norte de Londres.
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
Siguiente revisión prevista: 21 de mayo de 2028
22 May 2025 | Última versión

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita